Cardiocom releases new pulse oximeter

NewsGuard 100/100 Score

Cardiocom today announced the release of its new pulse oximeter.  Cardiocom's internally developed pulse oximeter offers better integration with its telehealth platform.  Cardiocom designs and manufactures telehealth communication devices and vital sign peripherals including: blood pressure system, weight scale, and now offers its new pulse oximeter.  The Company's vertical integration provides the highest quality telehealth system that is easy to use for patients and clinicians.  Cardiocom's new pulse oximeter is specifically suited for the home telehealth environment and was registered with the FDA in late 2009.  

"Cardiocom's segmented telehealth device platforms and vital sign monitoring peripherals provide a highly efficient and effortless user experience." says Daniel L. Cosentino, CEO and President.  "Cardiocom's decade of experience in telehealth, innovative products, and ancillary nurse service provides the best telehealth solutions to improve care for patients with complex chronic conditions."

Cardiocom's vertical integration ensures customers the highest quality, custom telehealth solutions at an affordable cost.  Cardiocom's suite of telehealth solutions has proven to significantly decrease unnecessary inpatient admissions and improve quality of care for integrated health systems, home health agencies, managed care organizations and specialty care companies.

SOURCE Cardiocom

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Immune cells play a bigger role in high blood pressure than previously thought, opening doors for new treatments